Methodological Concerns Regarding Codeine and Oxycodone Safety Comparisons in Hip Osteoarthritis [Letter]
Drug Design, Development and Therapy · 2026-08 · Volume 20 · 1-2
DOI: 10.2147/dddt.s645840 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2026-08. Verfasst von Jixin Shan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Sport Hospital of CDSU, Chengdu, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
We read with interest the nationwide retrospective cohort by Lee et al comparing psychiatric, cardiovascular and fracture risks between codeine and oxycodone in hip osteoarthritis (OA) patients using Korean HIRA claims data. 1 Its large sample and long follow-up offer preliminary clinical value, yet notable methodological limitations and unresolved residual confounding may weaken the interpretability of its core findings and clinical prescribing guidance, which we elaborate below.As administrative claims research, this study is plagued by unmeasured confounding that cannot be eliminated via statistical adjustment.HIRA records lack critical clinical metrics including baseline pain severity, physical impairment and formal hip OA staging.These unrecorded features simultaneously shape physicians' opioid prescribing decisions and independently raise risks of psychiatric adverse events, cardiovascular complications and fractures, generating persistent indication bias across all risk comparisons.A more striking flaw lies in extreme residual imbalance of concomitant tramadol use after 1:1 propensity score matching (PSM) with a 0.1 caliper width, where the standardized mean difference (SMD) reached 0.381.The authors set SMD
Autor:innen und Institutionen
- Affiliated Sport Hospital of CDSU, Chengdu, People's Republic of China.
- Orthopedics Department, China RongTong Medical Healthcare Group Co. Ltd., Bayi Orthopedic Hospital, Chengdu, People's Republic of China.
ORCID-Profile: Kewen Chen
Zitieren
APA
Shan, J., Chen, K., & Cen, Y. (2026). Methodological Concerns Regarding Codeine and Oxycodone Safety Comparisons in Hip Osteoarthritis [Letter]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s645840
Vancouver
Shan J, Chen K, Cen Y. Methodological Concerns Regarding Codeine and Oxycodone Safety Comparisons in Hip Osteoarthritis [Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s645840
BibTeX
@article{Shan2026,
author = {Shan, Jixin and Chen, Kewen and Cen, Yi},
title = {Methodological Concerns Regarding Codeine and Oxycodone Safety Comparisons in Hip Osteoarthritis [Letter]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--2},
doi = {10.2147/dddt.s645840}
}
EUVIMED